Authors: Davitt, BV Berdy, GJ Kane, RE

Citation: Bv. Davitt et al., Gastroesophageal reflux disease presenting as xerophthalmia, J PEDIAT OP, 38(5), 2001, pp. 315-317

Authors: Nelson, HS Kane, RE Petillo, J Banerji, D

Citation: Hs. Nelson et al., Long-term safety of a non-chlorofluorocarbon-containing triamcinolone acetonide inhalation aerosol in patients with asthma, J ASTHMA, 37(2), 2000, pp. 145-152

Authors: Jacobson, K Chervinsky, P Noonan, M Kane, RE Banerji, D Uryniak, T

Citation: K. Jacobson et al., Placebo-controlled, comparative study of the efficacy and safety of triamcinolone acetonide inhalation aerosol with the non-CFC propellant HFA-134a in patients with asthma, ANN ALLER A, 83(4), 1999, pp. 327-333

Authors: Welch, M Bernstein, D Gross, G Kane, RE Banerji, D

Citation: M. Welch et al., A controlled trial of chlorofluorocarbon-free triamcinolone acetonide inhalation aerosol in the treatment of adult patients with persistent asthma, CHEST, 116(5), 1999, pp. 1304-1312

Authors: Pearlman, DS Kane, RE Banerji, D

Citation: Ds. Pearlman et al., Comparative dose-ranging study of triamcinolone acetonide inhalation aerosol using propellants hydrofluoroalkane 134a or P-12 in children with chronic asthma, CURR THER R, 60(11), 1999, pp. 595-606